Life Science REIT will target a £300m raise when it floats on the AIM market of the London Stock Exchange next month, becoming the first London-listed real estate investment trust (REIT) focused on UK life science properties, with a £445m pipeline of projects.
- Home
- Uncategorised
- Life Science REIT IPO aims to raise £300m after lining up £445m investment pipeline